We are independent & ad-supported. We may earn a commission for purchases made through our links.

Advertiser Disclosure

Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.

How We Make Money

We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently from our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.

What Is Amineptine?

Tricia Christensen
Updated May 17, 2024
Our promise to you
WiseGeek is dedicated to creating trustworthy, high-quality content that always prioritizes transparency, integrity, and inclusivity above all else. Our ensure that our content creation and review process includes rigorous fact-checking, evidence-based, and continual updates to ensure accuracy and reliability.

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

Editorial Standards

At WiseGeek, we are committed to creating content that you can trust. Our editorial process is designed to ensure that every piece of content we publish is accurate, reliable, and informative.

Our team of experienced writers and editors follows a strict set of guidelines to ensure the highest quality content. We conduct thorough research, fact-check all information, and rely on credible sources to back up our claims. Our content is reviewed by subject matter experts to ensure accuracy and clarity.

We believe in transparency and maintain editorial independence from our advertisers. Our team does not receive direct compensation from advertisers, allowing us to create unbiased content that prioritizes your interests.

Amineptine is a medication that has only limited availability. First produced in France in the late 1970s and called Survector®, it was modeled on other tricyclic antidepressants (TCAs), although it is called an atypical TCA because it has slightly different action. Use of the medication created pronounced problems in a high percentage of people that warranted its removal from French markets. In places like the US, the Food and Drug Administration (FDA) never approved its use. People may sometimes find this medication available in their country of origin or online, but they should be certain they understand the potential side effects.

Many TCAs are selected serotonin and norepinephrine reuptake inhibitors or SNRIs. Amineptine, in contrast, inhibits the reuptake of norepinephrine and dopamine. In limited trials it seemed to function as well or better than some of the selected serotonin reuptake inhibitors (SSRIs) like Prozac®. Especially in the US, there haven’t been a number of studies on the drug because it may never be approved, given data gathered from other countries where it was sold.

One of the initial concerns about amineptine was that people began abusing it quickly. Those taking it noticed stimulant effects, producing a high, which many described as pleasant or euphoric. As a result, requests for the drug rose, or people sold their own prescriptions to others. The high typically didn’t remain with continued use and only could be experienced with occasional use.

As amineptine was prescribed more in France and a few other countries, additional reports manifested about potentially dangerous side effects. One of the most alarming concerned the possibility that the medication might cause liver damage or predispose some users to hepatitis. Other unpleasant or potentially dangerous side effects were linked to amineptine, including severe cases of acne, anaphylactic shock, and symptoms of excitation like akathisia and difficulty sleeping. It is presumed that teens and young adults taking it were probably at increased risk for suicidality and that people with bipolar disorder who took the medicine might develop mania or hypomania.

Rarely, low blood pressure and palpitations were seen with amineptine. A more concerning issue was the rumored potential for the drug to cause withdrawal symptoms when discontinued. The matter of antidepressant addiction is being more fully studied, and it appears there are a number of drugs that create withdrawal syndrome. Some of those most indicated are similar to typical tricyclic antidepressants and are SNRIs. Since amineptine acts in a similar way, it may hazard the same risks.

It’s difficult to recommend use of a medication that has been discontinued in many countries and not approved in others because of concerns about its safety. If people are interested in trying this TCA, it’s highly recommended they discuss their plans with a competent physician: preferably a psychiatrist with expertise in psychopharmacology. People are not advised to initiate amineptine therapy without the guidance and approval of a physician.

WiseGeek is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.
Tricia Christensen
By Tricia Christensen , Writer
With a Literature degree from Sonoma State University and years of experience as a WiseGeek contributor, Tricia Christensen is based in Northern California and brings a wealth of knowledge and passion to her writing. Her wide-ranging interests include reading, writing, medicine, art, film, history, politics, ethics, and religion, all of which she incorporates into her informative articles. Tricia is currently working on her first novel.

Discussion Comments

Tricia Christensen

Tricia Christensen


With a Literature degree from Sonoma State University and years of experience as a WiseGeek contributor, Tricia...
Learn more
WiseGeek, in your inbox

Our latest articles, guides, and more, delivered daily.

WiseGeek, in your inbox

Our latest articles, guides, and more, delivered daily.